{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:12Z","timestamp":1784557032830,"version":"3.55.0"},"reference-count":134,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["eo.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:p>Pituitary adenomas are benign neoplasms of the pituitary. The most prevalent are prolactinomas and non-functioning pituitary adenomas, followed by growth hormone- and ACTH-secreting adenomas. Most pituitary adenomas seem to be sporadic and their persistent growth is very atypical. No molecular markers predict their behavior. The occurrence of pituitary adenomas and malignancies in the same patient can be either pure coincidence or caused by shared underlying genetic susceptibility involved in tumorigenesis. Detailed family history on cancers\/tumors in the first, second and third generation of family members on each side of the family has been reported in a few studies. They found an association of pituitary tumors with positive family history for breast, lung and colorectal cancer. We have reported that in about 50% of patients with pituitary adenomas, an association with positive family history for cancer has been found independent of secretory phenotype (acromegaly, prolactinoma, Cushing\u02bcs disease or non-functioning pituitary adenomas). We also found earlier onset of pituitary tumors (younger age at diagnosis of pituitary tumors) in patients with a strong family history of cancer. In our recent unpublished series of 1300 patients with pituitary adenomas, 6.8% of patients were diagnosed with malignancy. The latency period between the diagnosis of pituitary adenoma and cancer was variable, and in 33% of patients, it was longer than 5 years. Besides the inherited trophic mechanisms (shared underlying genetic variants), the potential influence of shared complex epigenetic influences (environmental and behavioral factors \u2013 obesity, smoking, alcohol intake and insulin resistance) is discussed. Further studies are needed to better understand if patients with pituitary adenomas are at increased risk for cancer.<\/jats:p>","DOI":"10.1530\/eo-21-0033","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T09:24:16Z","timestamp":1640165056000},"page":"R1-R13","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":16,"title":["Pituitary tumors and the risk of other malignancies: is the relationship coincidental or causal?"],"prefix":"10.1530","volume":"2","author":[{"given":"Sandra","family":"Pekic","sequence":"first","affiliation":[{"name":"School of Medicine, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Belgrade, Serbia"},{"name":"Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Popovic","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Belgrade, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Neurooncology","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","unstructured":"Aflorei EDKorbonits M2014Epidemiology and etiopathogenesis of pituitary adenomas. Journal of Neurooncology117379\u2013394. (https:\/\/doi.org\/10.1007\/s11060-013-1354-5)10.1007\/s11060-013-1354-5"},{"key":"bib2","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1210\/jc.2009-1879","article-title":"Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene","volume":"95","author":"Aguiar-Oliveira","year":"2010","unstructured":"Aguiar-Oliveira MHOliveira FTPereira RMOliveira CRBlackford AValenca EHSantos EGGois-Junior MBMeneguz Moreno RAAraujo VP2010Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. Journal of Clinical Endocrinology and Metabolism95714\u2013721. (https:\/\/doi.org\/10.1210\/jc.2009-1879)10.1210\/jc.2009-1879"},{"key":"bib3","series-title":"Human Mutation","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/humu.21606","article-title":"SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours","volume":"32","author":"Alatzoglou","year":"2011","unstructured":"Alatzoglou KSAndoniadou CLKelberman DBuchanan CRCrolla JArriazu MCRoubick MMoncet DMartinez-Barbera JPDattani MT2011SOX2 haploinsufficiency is associated with slow progressing hypothalamo-pituitary tumours. Human Mutation321376\u20131380. (https:\/\/doi.org\/10.1002\/humu.21606)10.1002\/humu.21606"},{"key":"bib4","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/EJE-20-0795","article-title":"Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study","volume":"184","author":"Albertelli","year":"2021","unstructured":"Albertelli MNazzari EDotto AGrasso LFSciallero SPirchio RRebora ABoschetti MPivonello RRicci Bitti S2021Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study. European Journal of Endocrinology184419\u2013425. (https:\/\/doi.org\/10.1530\/EJE-20-0795)10.1530\/EJE-20-0795"},{"key":"bib5","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio","year":"2012","unstructured":"Arosio MReimondo GMalchiodi EBerchialla PBorraccino ADe Marinis LPivonello RGrottoli SLosa MCannav\u00f2 S2012Predictors of morbidity and mortality in acromegaly: an Italian survey. European Journal of Endocrinology167189\u2013198. (https:\/\/doi.org\/10.1530\/EJE-12-0084)10.1530\/EJE-12-0084"},{"key":"bib6","series-title":"Experimental and Clinical Endocrinology and Diabetes","first-page":"198","article-title":"Genetic alterations in differentiated thyroid cancer patients with acromegaly","volume":"124","author":"Aydin","year":"2016","unstructured":"Aydin KAydin CDagdelen STezel GGErbas T2016Genetic alterations in differentiated thyroid cancer patients with acromegaly. Experimental and Clinical Endocrinology and Diabetes 124198\u2013202. (https:\/\/doi.org\/10.1055\/s-0035-1565061)"},{"key":"bib7","series-title":"Endocrinology, Diabetes and Metabolism Case Reports","first-page":"20","article-title":"Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment","volume":"2020","author":"Barbosa","year":"2020","unstructured":"Barbosa MParedes SMachado MJAlmeida RMarques O2020Pituitary apoplexy induced by gonadotropin-releasing hormone agonist administration: a rare complication of prostate cancer treatment. Endocrinology, Diabetes and Metabolism Case Reports202020\u20130018. (https:\/\/doi.org\/10.1530\/EDM-20-0018)"},{"key":"bib8","series-title":"Current Topics in Developmental Biology","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0070-2153(04)63006-7","article-title":"Life extension in the dwarf mouse","volume":"63","author":"Bartke","year":"2004","unstructured":"Bartke ABrown-Borg H2004Life extension in the dwarf mouse. Current Topics in Developmental Biology63189\u2013225. (https:\/\/doi.org\/10.1016\/S0070-2153(0463006-7)10.1016\/S0070-2153(04)63006-7"},{"key":"bib9","series-title":"Growth Hormone and IGF Research","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ghir.2016.02.002","article-title":"The somatotropic axis and aging: benefits of endocrine defects","volume":"27","author":"Bartke","year":"2016","unstructured":"Bartke AList EOKopchick JJ2016The somatotropic axis and aging: benefits of endocrine defects. Growth Hormone and IGF Research 2741\u201345. (https:\/\/doi.org\/10.1016\/j.ghir.2016.02.002)10.1016\/j.ghir.2016.02.002"},{"key":"bib10","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11102-020-01090-8","article-title":"Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study","volume":"24","author":"Battistone","year":"2021","unstructured":"Battistone MFMiragaya KRogozinski AAg\u00fcero MAlfieri ABallarino MCBoero LDanilowicz KDiez SDonoso M2021Increased risk of preneoplastic colonic lesions and colorectal carcinoma in acromegaly: multicenter case-control study. Pituitary2496\u2013103. (https:\/\/doi.org\/10.1007\/s11102-020-01090-8)10.1007\/s11102-020-01090-8"},{"key":"bib11","series-title":"Growth Hormone and IGF Research","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ghir.2013.12.002","article-title":"Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly","volume":"24","author":"Bayram","year":"2014","unstructured":"Bayram FBitgen NDonmez-Altuntas HCakir IHamurcu ZSahin FSimsek YBaskol G2014Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly. Growth Hormone and IGF Research2429\u201334. (https:\/\/doi.org\/10.1016\/j.ghir.2013.12.002)10.1016\/j.ghir.2013.12.002"},{"key":"bib12","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1530\/EJE-11-0076","article-title":"Cancer risk in hyperprolactinemia patients: a population-based cohort study","volume":"165","author":"Berinder","year":"2011","unstructured":"Berinder KAkre OGranath FHulting AL2011Cancer risk in hyperprolactinemia patients: a population-based cohort study. European Journal of Endocrinology165209\u2013215. (https:\/\/doi.org\/10.1530\/EJE-11-0076)10.1530\/EJE-11-0076"},{"key":"bib13","series-title":"Journal of Medical Case Reports","article-title":"Giant prolactinoma, germline BRCA1 mutation, and depression: a case report","volume":"12","author":"Bettencourt-Silva","year":"2018","unstructured":"Bettencourt-Silva RQueir\u00f3s JPereira JCarvalho D2018Giant prolactinoma, germline BRCA1 mutation, and depression: a case report. Journal of Medical Case Reports12 360. (https:\/\/doi.org\/10.1186\/s13256-018-1890-x)"},{"key":"bib14","series-title":"Endocrinology","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/en.2016-1967","article-title":"Clinical identification of oncogenic drivers and copy number alterations in pituitary tumors","volume":"158","author":"Bi","year":"2017","unstructured":"Bi WLGreenwald NFRamkissoon SHAbedalthagafi MCoy SMLigon KLMei YMacConaill LDucar MMin L2017Clinical identification of oncogenic drivers and copy number alterations in pituitary tumors. Endocrinology1582284\u20132291. (https:\/\/doi.org\/10.1210\/en.2016-1967)10.1210\/en.2016-1967"},{"key":"bib15","series-title":"Current Neurology and Neuroscience Reports","article-title":"Genomic alterations in sporadic pituitary tumors","volume":"18","author":"Bi","year":"2018","unstructured":"Bi WLLarsen AGDunn IF2018Genomic alterations in sporadic pituitary tumors. Current Neurology and Neuroscience Reports18 4. (https:\/\/doi.org\/10.1007\/s11910-018-0811-0)"},{"key":"bib16","series-title":"Biotechnic and Histochemistry","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3109\/10520295.2015.1101163","article-title":"Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma","volume":"91","author":"Bitgen","year":"2016","unstructured":"Bitgen NDonmez-Altuntas HBayram FCakir IHamurcu ZDiri HBaskol GSenol SDurak AC2016Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma. Biotechnic and Histochemistry 91128\u2013136. (https:\/\/doi.org\/10.3109\/10520295.2015.1101163)10.3109\/10520295.2015.1101163"},{"key":"bib17","series-title":"Endokrynologia Polska","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5603\/EP.a2020.0084","article-title":"Chromosomal and oxidative DNA damage in non-functioning pituitary adenomas","volume":"72","author":"Bitgen","year":"2021","unstructured":"Bitgen NBayram FHamurcu ZOzturk FSimsek YBaskol GKurtsoy ADonmez-Altuntas H2021Chromosomal and oxidative DNA damage in non-functioning pituitary adenomas. Endokrynologia Polska7297\u2013103. (https:\/\/doi.org\/10.5603\/EP.a2020.0084)10.5603\/EP.a2020.0084"},{"key":"bib18","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-13-0166","article-title":"Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study","volume":"169","author":"Bogazzi","year":"2013","unstructured":"Bogazzi FColao ARossi GLombardi MUrbani CSardella CIannelli AScattina IManetti LDel Sarto S2013Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. European Journal of Endocrinology169367\u2013376. (https:\/\/doi.org\/10.1530\/EJE-13-0166)10.1530\/EJE-13-0166"},{"key":"bib19","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"R147","DOI":"10.1530\/EJE-16-0178","article-title":"Management of endocrine disease: acromegaly and cancer: an old debate revisited","volume":"175","author":"Boguszewski","year":"2016","unstructured":"Boguszewski CLAyuk J2016Management of endocrine disease: acromegaly and cancer: an old debate revisited. European Journal of Endocrinology175R147\u2013R156. (https:\/\/doi.org\/10.1530\/EJE-16-0178)10.1530\/EJE-16-0178"},{"key":"bib20","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1210\/er.2018-00166","article-title":"Growth hormone\u2019s links to cancer","volume":"40","author":"Boguszewski","year":"2019","unstructured":"Boguszewski CLBoguszewski MCDS2019Growth hormone\u2019s links to cancer. Endocrine Reviews40558\u2013574. (https:\/\/doi.org\/10.1210\/er.2018-00166)10.1210\/er.2018-00166"},{"key":"bib21","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","unstructured":"Bolfi FNeves AFBoguszewski CLNunes-Nogueira VS2018Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis. European Journal of Endocrinology17959\u201371. (https:\/\/doi.org\/10.1530\/EJE-18-0255)10.1530\/EJE-18-0255"},{"key":"bib22","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/eje.1.02107","article-title":"Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data","volume":"154","author":"Burman","year":"2006","unstructured":"Burman HSaeger W2006Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. European Journal of Endocrinology154753\u2013758. (https:\/\/doi.org\/10.1530\/eje.1.02107)10.1530\/eje.1.02107"},{"key":"bib23","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1530\/EJE-10-0465","article-title":"Increased prevalence of acromegaly in a highly polluted area","volume":"163","author":"Cannav\u00f2","year":"2010","unstructured":"Cannav\u00f2 SFerra\u00f9 FRagonese MCurt\u00f2 LTorre MLMagistri MMarchese AAlibrandi ATrimarchi F2010Increased prevalence of acromegaly in a highly polluted area. European Journal of Endocrinology163509\u2013513. (https:\/\/doi.org\/10.1530\/EJE-10-0465)10.1530\/EJE-10-0465"},{"key":"bib24","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1210\/jc.2015-4191","article-title":"Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas","volume":"101","author":"Cannavo","year":"2016","unstructured":"Cannavo SRagonese MPuglisi SRomeo PDTorre MLAlibrandi AScaroni COcchi GCeccato FRegazzo D2016Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas. Journal of Clinical Endocrinology and Metabolism1011872\u20131879. (https:\/\/doi.org\/10.1210\/jc.2015-4191)10.1210\/jc.2015-4191"},{"key":"bib25","series-title":"Molecular and Cellular Endocrinology","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mce.2016.12.019","article-title":"Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden","volume":"457","author":"Cannavo","year":"2017","unstructured":"Cannavo STrimarchi FFerra\u00f9 F2017Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden. Molecular and Cellular Endocrinology45781\u201388. (https:\/\/doi.org\/10.1016\/j.mce.2016.12.019)10.1016\/j.mce.2016.12.019"},{"key":"bib26","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","unstructured":"Chahal HSTrivellin GLeontiou CAAlband NFowkes RCTahir AIgreja SCChapple JPJordan SLupp A2012Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway. Journal of Clinical Endocrinology and Metabolism97E1411\u2013E1420. (https:\/\/doi.org\/10.1210\/jc.2012-1111)10.1210\/jc.2012-1111"},{"key":"bib27","series-title":"Nature Communications","article-title":"Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease","volume":"9","author":"Chen","year":"2018","unstructured":"Chen JJian XDeng SMa ZShou XShen YZhang QSong ZLi ZPeng H2018Identification of recurrent USP48 and BRAF mutations in Cushing\u2019s disease. Nature Communications9 3171. (https:\/\/doi.org\/10.1038\/s41467-018-05275-5)"},{"key":"bib28","series-title":"PNAS","first-page":"E3250","article-title":"Growth hormone is permissive for neoplastic colon growth","volume":"113","author":"Chesnokova","year":"2016","unstructured":"Chesnokova VZonis SZhou CRecouvreux MVBen-Shlomo AAraki TBarrett RWorkman MWawrowsky KLjubimov VA2016Growth hormone is permissive for neoplastic colon growth. PNAS113E3250\u2013E3259. (https:\/\/doi.org\/10.1073\/pnas.1600561113)"},{"key":"bib29","series-title":"Endocrinology","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1210\/en.2019-00132","article-title":"Growth hormone induces colon DNA damage independent of IGF-1","volume":"160","author":"Chesnokova","year":"2019","unstructured":"Chesnokova VZonis SBarrett RJGleeson JPMelmed S2019Growth hormone induces colon DNA damage independent of IGF-1. Endocrinology1601439\u20131447. (https:\/\/doi.org\/10.1210\/en.2019-00132)10.1210\/en.2019-00132"},{"key":"bib30","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-14-1123","article-title":"Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the hypopituitary control and complications study","volume":"172","author":"Child","year":"2015","unstructured":"Child CJConroy DZimmermann AGWoodmansee WWErfurth EMRobison LL2015Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the hypopituitary control and complications study. European Journal of Endocrinology172779\u2013790. (https:\/\/doi.org\/10.1530\/EJE-14-1123)10.1530\/EJE-14-1123"},{"key":"bib31","series-title":"Toxicology and Applied Pharmacology","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/taap.1999.8840","article-title":"High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line","volume":"162","author":"Chun","year":"2000","unstructured":"Chun TYGorski J2000High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line. Toxicology and Applied Pharmacology162161\u2013165. (https:\/\/doi.org\/10.1006\/taap.1999.8840)10.1006\/taap.1999.8840"},{"key":"bib32","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2001-0036","article-title":"The role of prolactin in mammary carcinoma","volume":"24","author":"Clevenger","year":"2003","unstructured":"Clevenger CVFurth PAHankinson SESchuler LA2003The role of prolactin in mammary carcinoma. Endocrine Reviews241\u201327. (https:\/\/doi.org\/10.1210\/er.2001-0036)10.1210\/er.2001-0036"},{"key":"bib33","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/EJE-13-1022","article-title":"Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)","volume":"171","author":"Colao","year":"2014","unstructured":"Colao AVandeva SPivonello RGrasso LFNachev EAuriemma RSKalinov KZacharieva S2014Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy). European Journal of Endocrinology171263\u2013273. (https:\/\/doi.org\/10.1530\/EJE-13-1022)10.1530\/EJE-13-1022"},{"key":"bib34","series-title":"Journal of Neurosurgery","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.3171\/2014.8.JNS132139","article-title":"Co-prevalence of other tumors in patients harboring pituitary tumors","volume":"121","author":"Couldwell","year":"2014","unstructured":"Couldwell WTCannon-Albright LA2014Co-prevalence of other tumors in patients harboring pituitary tumors. Journal of Neurosurgery1211474\u20131477. (https:\/\/doi.org\/10.3171\/2014.8.JNS132139)10.3171\/2014.8.JNS132139"},{"key":"bib35","series-title":"Endocrinology and Metabolism Clinics of North America","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The epidemiology of pituitary adenomas","volume":"49","author":"Daly","year":"2020","unstructured":"Daly AFBeckers A2020The epidemiology of pituitary adenomas. Endocrinology and Metabolism Clinics of North America49347\u2013355. (https:\/\/doi.org\/10.1016\/j.ecl.2020.04.002)10.1016\/j.ecl.2020.04.002"},{"key":"bib36","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-009-0214-y","article-title":"The risk for breast cancer is not evidently increased in women with hyperprolactinemia","volume":"13","author":"Dekkers","year":"2010","unstructured":"Dekkers OMRomijn JAde Boer AVandenbroucke JP2010The risk for breast cancer is not evidently increased in women with hyperprolactinemia. Pituitary13195\u2013198. (https:\/\/doi.org\/10.1007\/s11102-009-0214-y)10.1007\/s11102-009-0214-y"},{"key":"bib37","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1530\/EJE-15-0282","article-title":"Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature","volume":"173","author":"Dekkers","year":"2015","unstructured":"Dekkers OMEhrenstein VBengtsen MFarkas DKPereira AMSorensen HTJorgensen JO2015Breast cancer risk in hyperprolactinemia: a population-based cohort study and meta-analysis of the literature. European Journal of Endocrinology173269\u2013273. (https:\/\/doi.org\/10.1530\/EJE-15-0282)10.1530\/EJE-15-0282"},{"key":"bib38","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1530\/EJE-14-0990","article-title":"Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth","volume":"172","author":"Delgrange","year":"2015","unstructured":"Delgrange EVasiljevic AWierinckx AFrancois PJouanneau ERaverot GTrouillas J2015Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. European Journal of Endocrinology172791\u2013801. (https:\/\/doi.org\/10.1530\/EJE-14-0990)10.1530\/EJE-14-0990"},{"key":"bib39","series-title":"Hormones","doi-asserted-by":"publisher","first-page":"189","DOI":"10.14310\/horm.2002.1346","article-title":"Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective","volume":"11","author":"Doknic","year":"2012","unstructured":"Doknic MPekic SCivcic MPopovic V2012Clinical Case Seminar. Peculiar prolactinomas in patients with pituitary developmental gene mutations: from an adult endocrinologist perspective. Hormones11189\u2013198. (https:\/\/doi.org\/10.14310\/horm.2002.1346)10.14310\/horm.2002.1346"},{"key":"bib40","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s11102-020-01117-0","article-title":"Extending lifespan by modulating the growth hormone\/insulin-like growth factor-1 axis: coming of age","volume":"24","author":"Duran-Ortiz","year":"2021","unstructured":"Duran-Ortiz SList EOBasu RKopchick JJ2021Extending lifespan by modulating the growth hormone\/insulin-like growth factor-1 axis: coming of age. Pituitary24438\u2013456. (https:\/\/doi.org\/10.1007\/s11102-020-01117-0)10.1007\/s11102-020-01117-0"},{"key":"bib41","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"659","article-title":"Incidence of a second tumor in hypopituitary patients operated for pituitary tumors","volume":"86","author":"Erfurth","year":"2001","unstructured":"Erfurth EMBullow BMikoczy ZHagmar L2001Incidence of a second tumor in hypopituitary patients operated for pituitary tumors. Journal of Clinical Endocrinology and Metabolism86659\u2013662. (https:\/\/doi.org\/10.1210\/jcem.86.2.7234)"},{"key":"bib42","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a Nationwide Study","volume":"178","author":"Esposito","year":"2018","unstructured":"Esposito DRagnarsson OGranfeldt DMarlow TJohannsson GOlsson DS2018Decreasing mortality and changes in treatment patterns in patients with acromegaly from a Nationwide Study. European Journal of Endocrinology178459\u2013469. (https:\/\/doi.org\/10.1530\/EJE-18-0015)10.1530\/EJE-18-0015"},{"key":"bib43","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"3487","article-title":"Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study","volume":"106","author":"Esposito","year":"2021","unstructured":"Esposito DRagnarsson OJohannsson GOlsson DS2021Incidence of benign and malignant tumors in patients with acromegaly is increased: a nationwide population-based study. Journal of Clinical Endocrinology and Metabolism1063487\u20133496. (https:\/\/doi.org\/10.1210\/clinem\/dgab560)"},{"key":"bib44","series-title":"Journal of Endocrinological Investigation","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/BF03351047","article-title":"Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male","volume":"24","author":"Forloni","year":"2001","unstructured":"Forloni FGiovilli MPecis CBortolani EPreziosi ABarzaghi MECorti DBeck-Peccoz P2001Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. Journal of Endocrinological Investigation24454\u2013459. (https:\/\/doi.org\/10.1007\/BF03351047)10.1007\/BF03351047"},{"key":"bib45","series-title":"Environmental Research","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.envres.2017.07.015","article-title":"Effects of environmental pollutants on signaling pathways in rat pituitary GH3 adenoma cells","volume":"158","author":"Fortunati","year":"2017","unstructured":"Fortunati NGuaraldi FZunino VPenner FD\u2019Angelo VZenga FPecori Giraldi FCatalano MGArvat E2017Effects of environmental pollutants on signaling pathways in rat pituitary GH3 adenoma cells. Environmental Research158660\u2013668. (https:\/\/doi.org\/10.1016\/j.envres.2017.07.015)10.1016\/j.envres.2017.07.015"},{"key":"bib46","series-title":"Journal of Toxicologic Pathology","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1293\/tox.14.65","article-title":"Effects of endocrine disruptors on the pituitary gland","volume":"14","author":"Fujimoto","year":"2001","unstructured":"Fujimoto N2001Effects of endocrine disruptors on the pituitary gland. Journal of Toxicologic Pathology1465\u201369. (https:\/\/doi.org\/10.1293\/tox.14.65)10.1293\/tox.14.65"},{"key":"bib47","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","unstructured":"Gadelha MRKasuki LLim DSTFleseriu M2019Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocrine Reviews40268\u2013332. (https:\/\/doi.org\/10.1210\/er.2018-00115)10.1210\/er.2018-00115"},{"key":"bib48","series-title":"Journal of Clinical Endocrinology and Metabolism","article-title":"A consensus on the diagnosis and treatment of acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","unstructured":"Giustina ABarkan ABeckers ABiermasz NBiller BMKBoguszewski CBolanowski MBonert VBronstein MDCasanueva FF2020A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. Journal of Clinical Endocrinology and Metabolism105 dgz096. (https:\/\/doi.org\/10.1210\/clinem\/dgz096)"},{"key":"bib49","series-title":"Nature Communications","article-title":"Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans","volume":"12","author":"Gualtieri","year":"2021","unstructured":"Gualtieri AKyprianou NGregory LCVignola MLNicholson JGTan RInoue SIScagliotti VCasado PBlackburn J2021Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans. Nature Communications12 2028. (https:\/\/doi.org\/10.1038\/s41467-021-21712-4)"},{"key":"bib50","series-title":"Science Translational Medicine","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","unstructured":"Guevara-Aguirre JBalasubramanian PGuevara-Aguirre MWei MMadia FCheng CWHwang DMartin-Montalvo ASaavedra JIngles S2011Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Science Translational Medicine3 70ra13. (https:\/\/doi.org\/10.1126\/scitranslmed.3001845)"},{"key":"bib51","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s11102-010-0224-9","article-title":"Thyroid cancer is the most common cancer associated with acromegaly","volume":"13","author":"Gullu","year":"2010","unstructured":"Gullu BECelik OGazioglu NKadioglu P2010Thyroid cancer is the most common cancer associated with acromegaly. Pituitary13242\u2013248. (https:\/\/doi.org\/10.1007\/s11102-010-0224-9)10.1007\/s11102-010-0224-9"},{"key":"bib52","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1210\/jc.2017-02287","article-title":"Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas","volume":"103","author":"Hage","year":"2018","unstructured":"Hage MViengchareun SBrunet EVilla CPineau DBouligand JTeglas JPAdam CParker FLomb\u00e8s M2018Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas. Journal of Clinical Endocrinology and Metabolism1031929\u20131939. (https:\/\/doi.org\/10.1210\/jc.2017-02287)10.1210\/jc.2017-02287"},{"key":"bib53","series-title":"Annals of Internal Medicine","doi-asserted-by":"publisher","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","unstructured":"Hall WALuciano MGDoppman JLPatronas NJOldfield EH1994Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Annals of Internal Medicine120817\u2013820. (https:\/\/doi.org\/10.7326\/0003-4819-120-10-199405150-00001)10.7326\/0003-4819-120-10-199405150-00001"},{"key":"bib54","series-title":"Ecotoxicology and Environmental Safety","doi-asserted-by":"publisher","first-page":"112136","DOI":"10.1016\/j.ecoenv.2021.112136","article-title":"Combined toxicity of endocrine-disrupting chemicals: a review","volume":"215","author":"Hamid","year":"2021","unstructured":"Hamid NJunaid MPei DS2021Combined toxicity of endocrine-disrupting chemicals: a review. Ecotoxicology and Environmental Safety215112136. (https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112136)10.1016\/j.ecoenv.2021.112136"},{"key":"bib55","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/EJE-18-0370","article-title":"Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement","volume":"179","author":"Hammarstrand","year":"2018","unstructured":"Hammarstrand CRagnarsson OBengtsson OBryngelsson ILJohannsson GOlsson DS2018Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement. European Journal of Endocrinology179229\u2013237. (https:\/\/doi.org\/10.1530\/EJE-18-0370)10.1530\/EJE-18-0370"},{"key":"bib56","series-title":"Metabolism: Clinical and Experimental","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.metabol.2011.03.013","article-title":"Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly","volume":"60","author":"Hamurcu","year":"2011","unstructured":"Hamurcu ZCakir IDonmez-Altuntas HBitgen NKaraca ZElbuken GBayram F2011Micronucleus evaluation in mitogen-stimulated lymphocytes of patients with acromegaly. Metabolism: Clinical and Experimental601620\u20131626. (https:\/\/doi.org\/10.1016\/j.metabol.2011.03.013)10.1016\/j.metabol.2011.03.013"},{"key":"bib57","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"dgab748","article-title":"Non-functioning pituitary microadenomas, should imaging interval be extended? A large single-center cohort study","author":"Han","year":"2021","unstructured":"Han AJVarlamov EVFleseriu M2021Non-functioning pituitary microadenomas, should imaging interval be extended? A large single-center cohort study. Journal of Clinical Endocrinology and Metabolismdgab748. (https:\/\/doi.org\/10.1210\/clinem\/dgab748)"},{"key":"bib58","series-title":"Journal of Breast Cancer","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4048\/jbc.2020.23.e63","article-title":"Whole exome sequencing in the male breast cancer with prolactinoma: a case report and literature review","volume":"23","author":"Hao","year":"2020","unstructured":"Hao SHuang MTian WChen YZhao JLuo D2020Whole exome sequencing in the male breast cancer with prolactinoma: a case report and literature review. Journal of Breast Cancer23656\u2013664. (https:\/\/doi.org\/10.4048\/jbc.2020.23.e63)10.4048\/jbc.2020.23.e63"},{"key":"bib59","series-title":"Modern Pathology","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41379-020-0523-2","article-title":"Telomere length alterations and ATRX\/DAXX loss in pituitary adenomas","volume":"33","author":"Heaphy","year":"2020","unstructured":"Heaphy CMBi WLCoy SDavis CGallia GLSantagata SRodriguez FJ2020Telomere length alterations and ATRX\/DAXX loss in pituitary adenomas. Modern Pathology 331475\u20131481. (https:\/\/doi.org\/10.1038\/s41379-020-0523-2)10.1038\/s41379-020-0523-2"},{"key":"bib60","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1677\/ERC-06-0008","article-title":"Incidence and familial risks in pituitary adenoma and associated tumors","volume":"14","author":"Hemminki","year":"2007","unstructured":"Hemminki KF\u00f6rsti AJi J2007Incidence and familial risks in pituitary adenoma and associated tumors. Endocrine-Related Cancer14103\u2013109. (https:\/\/doi.org\/10.1677\/ERC-06-0008)10.1677\/ERC-06-0008"},{"key":"bib61","series-title":"Journal of the Endocrine Society","article-title":"Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time?","volume":"5","author":"Ho","year":"2021","unstructured":"Ho KFleseriu MKaiser USalvatori RBrue TLopes MBKunz PMolitch MCamper SAGadelha M2021Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time?Journal of the Endocrine Society5 bvaa205. (https:\/\/doi.org\/10.1210\/jendso\/bvaa205)"},{"key":"bib62","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","unstructured":"Holdaway IMRajasoorya RCGamble GD2004Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism89667\u2013674. (https:\/\/doi.org\/10.1210\/jc.2003-031199)10.1210\/jc.2003-031199"},{"key":"bib63","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/clinem\/dgab275","article-title":"Ovarian hyperandrogenism and response to gonadotropin-releasing hormone analogues in primary severe insulin resistance","volume":"106","author":"Huang-Doran","year":"2021","unstructured":"Huang-Doran IKinzer ABJimenez-Linan MThackray KHarris JAdams CLde Kerdanet MStears AO\u2019Rahilly SSavage DB2021Ovarian hyperandrogenism and response to gonadotropin-releasing hormone analogues in primary severe insulin resistance. Journal of Clinical Endocrinology and Metabolism1062367\u20132383. (https:\/\/doi.org\/10.1210\/clinem\/dgab275)10.1210\/clinem\/dgab275"},{"key":"bib64","series-title":"Journals of Gerontology: Series A, Biological Sciences and Medical Sciences","first-page":"522","article-title":"Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor\/binding protein knockout mice","volume":"64","author":"Ikeno","year":"2009","unstructured":"Ikeno YHubbard GBLee SCortez LALew CMWebb CRBerryman DEList EOKopchick JJBartke A2009Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor\/binding protein knockout mice. Journals of Gerontology: Series A, Biological Sciences and Medical Sciences64522\u2013529. (https:\/\/doi.org\/10.1093\/gerona\/glp017)"},{"key":"bib65","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1210\/jcem.86.7.7634","article-title":"Clinical perspective: acromegaly and cancer: a problem","volume":"86","author":"Jenkins","year":"2001","unstructured":"Jenkins PJBesser M2001Clinical perspective: acromegaly and cancer: a problem. Journal of Clinical Endocrinology and Metabolism862935\u20132941. (https:\/\/doi.org\/10.1210\/jcem.86.7.7634)10.1210\/jcem.86.7.7634"},{"key":"bib66","series-title":"International Journal of Molecular Sciences","article-title":"Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer","volume":"22","author":"Kasprzak","year":"2021","unstructured":"Kasprzak A2021Insulin-like growth factor 1 (IGF-1) signaling in glucose metabolism in colorectal cancer. International Journal of Molecular Sciences22 6434. (https:\/\/doi.org\/10.3390\/ijms22126434)"},{"key":"bib67","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly","volume":"90","author":"Kauppinen-Makelin","year":"2005","unstructured":"Kauppinen-Makelin RSane TReunanen AValimaki MJNiskanen LMarkkanen HLoyttyniemi EEbeling TJaatinen PLaine H2005A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism904081\u20134086. (https:\/\/doi.org\/10.1210\/jc.2004-1381)10.1210\/jc.2004-1381"},{"key":"bib68","series-title":"Scientific Reports","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/s41598-021-97864-6","article-title":"Bisphenol-A in biological samples of breast cancer mastectomy and mammoplasty patients and correlation with levels measured in urine and tissue","volume":"11","author":"Keshavarz-Maleki","year":"2021","unstructured":"Keshavarz-Maleki RKaviani AOmranipour RGholami MKhoshayand MROstad SNSabzevari O2021Bisphenol-A in biological samples of breast cancer mastectomy and mammoplasty patients and correlation with levels measured in urine and tissue. Scientific Reports1118411. (https:\/\/doi.org\/10.1038\/s41598-021-97864-6)10.1038\/s41598-021-97864-6"},{"key":"bib69","series-title":"Environmental Health Perspectives","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1289\/ehp.0800182","article-title":"Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3\/B6\/F10 somatomammotropes","volume":"117","author":"Kochukov","year":"2009","unstructured":"Kochukov MYJeng YJWatson CS2009Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH3\/B6\/F10 somatomammotropes. Environmental Health Perspectives117723\u2013730. (https:\/\/doi.org\/10.1289\/ehp.0800182)10.1289\/ehp.0800182"},{"key":"bib70","series-title":"Acta Biochimica Polonica","doi-asserted-by":"publisher","first-page":"51","DOI":"10.18388\/abp.2016_1425","article-title":"The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues","volume":"65","author":"Krol","year":"2018","unstructured":"Krol MBGalicki MGresner PWieczorek EJablonska EReszka EMorawiec ZW\u0105sowicz WGromadzi\u0144ska J2018The ESR1 and GPX1 gene expression level in human malignant and non-malignant breast tissues. Acta Biochimica Polonica6551\u201357. (https:\/\/doi.org\/10.18388\/abp.2016_1425)10.18388\/abp.2016_1425"},{"key":"bib71","series-title":"Pediatric Endocrinology Reviews","first-page":"357","article-title":"Longevity of the hypopituitary patients from the island Krk: a follow-up study","volume":"7","author":"Krzisnik","year":"2010","unstructured":"Krzisnik CGrguric SCvijovic KLaron Z2010Longevity of the hypopituitary patients from the island Krk: a follow-up study. Pediatric Endocrinology Reviews 7357\u2013362."},{"key":"bib72","series-title":"Biomedical and Environmental Sciences","first-page":"192","article-title":"Aryl hydrocarbon receptor is involved in the proinflammatory cytokine response to cadmium","volume":"34","author":"Kulas","year":"2021","unstructured":"Kulas JTucovic DZeljkovic MPopovic DPopov Aleksandrov AKataranovski MMirkov I2021Aryl hydrocarbon receptor is involved in the proinflammatory cytokine response to cadmium. Biomedical and Environmental Sciences 34192\u2013202. (https:\/\/doi.org\/10.3967\/bes2021.025)"},{"key":"bib73","series-title":"Acta Neuropathologica Communications","article-title":"Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis","volume":"8","author":"Lasolle","year":"2020","unstructured":"Lasolle HElsensohn MHWierinckx AAlix EBonnefille CVasiljevic ACortet CDecoudier BSturm NGaillard S2020Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis. Acta Neuropathologica Communications8 190. (https:\/\/doi.org\/10.1186\/s40478-020-01067-5)"},{"key":"bib74","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","unstructured":"Leontiou CAGueorguiev Mvan der Spuy JQuinton RLolli FHassan SChahal HSIgreja SCJordan SRowe J2008The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism932390\u20132401. (https:\/\/doi.org\/10.1210\/jc.2007-2611)10.1210\/jc.2007-2611"},{"issue":"Supplement 1","key":"bib75","series-title":"Hormone Research in Paediatrics","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000329114","article-title":"Molecular and trophic mechanisms of pituitary tumourigenesis","volume":"76","author":"Levy","year":"2011","unstructured":"Levy A2011Molecular and trophic mechanisms of pituitary tumourigenesis. Hormone Research in Paediatrics76 (Supplement 1) 2\u20136. (https:\/\/doi.org\/10.1159\/000329114)10.1159\/000329114"},{"key":"bib76","series-title":"Frontiers in Neuroendocrinology","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0091-3022(03)00012-8","article-title":"Molecular defects in the pathogenesis of pituitary tumours","volume":"24","author":"Levy","year":"2003","unstructured":"Levy ALightman S2003Molecular defects in the pathogenesis of pituitary tumours. Frontiers in Neuroendocrinology2494\u2013127. (https:\/\/doi.org\/10.1016\/s0091-3022(0300012-8)10.1016\/S0091-3022(03)00012-8"},{"key":"bib77","series-title":"Breast Cancer Research and Treatment","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1023\/A:1023956223037","article-title":"Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth","volume":"79","author":"Liby","year":"2003","unstructured":"Liby KNeltner BMohamet LMenchen LBen-Jonathan N2003Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Research and Treatment79241\u2013252. (https:\/\/doi.org\/10.1023\/a:1023956223037)10.1023\/A:1023956223037"},{"key":"bib78","series-title":"Endocrine Practice","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4158\/EP-2018-0034","article-title":"Update on the clinicopathology of pituitary adenomas","volume":"24","author":"Lim","year":"2018","unstructured":"Lim CTKorbonits M2018Update on the clinicopathology of pituitary adenomas. Endocrine Practice 24473\u2013488. (https:\/\/doi.org\/10.4158\/EP-2018-0034)10.4158\/EP-2018-0034"},{"key":"bib79","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12020-013-0125-6","article-title":"The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas","volume":"46","author":"Lloyd","year":"2014","unstructured":"Lloyd CGrossman A2014The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas. Endocrine46387\u2013396. (https:\/\/doi.org\/10.1007\/s12020-013-0125-6)10.1007\/s12020-013-0125-6"},{"key":"bib80","series-title":"Reviews in Endocrine and Metabolic Disorders","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11154-007-9063-z","article-title":"Acromegaly: re-thinking the cancer risk","volume":"9","author":"Loeper","year":"2008","unstructured":"Loeper SEzzat S2008Acromegaly: re-thinking the cancer risk. Reviews in Endocrine and Metabolic Disorders941\u201358. (https:\/\/doi.org\/10.1007\/s11154-007-9063-z)10.1007\/s11154-007-9063-z"},{"key":"bib81","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","unstructured":"Maione LBrue TBeckers ADelemer BPetrossians PBorson-Chazot FChabre OFran\u00e7ois PBertherat JCortet-Rudelli C2017Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. European Journal of Endocrinology176645\u2013655. (https:\/\/doi.org\/10.1530\/EJE-16-1064)10.1530\/EJE-16-1064"},{"key":"bib82","series-title":"BMJ Case Reports","first-page":"bcr0120091421","article-title":"A rare case of male breast ductal carcinoma in-situ associated with prolactinoma","volume":"2011","author":"Mallawaarachchi","year":"2011","unstructured":"Mallawaarachchi CMIvanova SShorthouse AShousha SSinnett D2011A rare case of male breast ductal carcinoma in-situ associated with prolactinoma. BMJ Case Reports2011bcr0120091421. (https:\/\/doi.org\/10.1136\/bcr.01.2009.1421)"},{"key":"bib83","series-title":"Endocrine Journal","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1507\/endocrj.46.513","article-title":"Growth stimulation of a rat pituitary cell line MtT\/E-2 by environmental estrogens in vitro and in vivo","volume":"46","author":"Maruyama","year":"1999","unstructured":"Maruyama SFujimoto NYin HIto A1999Growth stimulation of a rat pituitary cell line MtT\/E-2 by environmental estrogens in vitro and in vivo. Endocrine Journal46513\u2013520. (https:\/\/doi.org\/10.1507\/endocrj.46.513)10.1507\/endocrj.46.513"},{"key":"bib84","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","unstructured":"McCormack ADekkers OMPetersenn SPopovic VTrouillas JRaverot GBurman P & ESE Survey Collaborators2018Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. European Journal of Endocrinology178265\u2013276. (https:\/\/doi.org\/10.1530\/EJE-17-0933)10.1530\/EJE-17-0933"},{"key":"bib85","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","unstructured":"Melmed S2020Pituitary-tumor endocrinopathies. New England Journal of Medicine382937\u2013950. (https:\/\/doi.org\/10.1056\/NEJMra1810772)10.1056\/NEJMra1810772"},{"key":"bib86","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","unstructured":"Mercado MGonzalez BVargas GRamirez Cde los Monteros ALSosa EJervis PRoldan PMendoza VL\u00f3pez-F\u00e9lix B2014Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. Journal of Clinical Endocrinology and Metabolism994438\u20134446. (https:\/\/doi.org\/10.1210\/jc.2014-2670)10.1210\/jc.2014-2670"},{"key":"bib87","series-title":"PLoS ONE","article-title":"AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up","volume":"9","author":"Mian","year":"2014","unstructured":"Mian CCeccato FBarollo SWatutantrige-Fernando SAlbiger NRegazzo Dde Lazzari PPennelli GRotondi SNacamulli D2014AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up. PLoS ONE9 e101560. (https:\/\/doi.org\/10.1371\/journal.pone.0101560)"},{"key":"bib88","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1210\/jc.2004-1152","article-title":"Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years","volume":"90","author":"Minniti","year":"2005","unstructured":"Minniti GTraish DAshley SGonsalves ABrada M2005Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. Journal of Clinical Endocrinology and Metabolism90800\u2013804. (https:\/\/doi.org\/10.1210\/jc.2004-1152)10.1210\/jc.2004-1152"},{"key":"bib89","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","unstructured":"Molitch ME2017Diagnosis and treatment of pituitary adenomas: a review. JAMA317516\u2013524. (https:\/\/doi.org\/10.1001\/jama.2016.19699)10.1001\/jama.2016.19699"},{"key":"bib90","series-title":"Annals of Oncology","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.annonc.2020.01.066","article-title":"Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with \u223c430 000 women","volume":"31","author":"Murphy","year":"2020","unstructured":"Murphy NKnuppel APapadimitriou NMartin RMTsilidis KKSmith-Byrne KFensom GPerez-Cornago ATravis RCKey TJ2020Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with \u223c430 000 women. Annals of Oncology 31641\u2013649. (https:\/\/doi.org\/10.1016\/j.annonc.2020.01.066)10.1016\/j.annonc.2020.01.066"},{"key":"bib91","series-title":"Cancer Cell","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","unstructured":"Neou MVilla CArmignacco RJouinot ARaffin-Sanson MLSeptier ALetourneur FDiry SDiedisheim MIzac B2020Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell37123\u2013134.e5. (https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002)10.1016\/j.ccell.2019.11.002"},{"key":"bib92","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1365-2265.2007.03118.x","article-title":"Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours","volume":"68","author":"Norberg","year":"2008","unstructured":"Norberg LJohansson RRasmuson T2008Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours. Clinical Endocrinology68780\u2013785. (https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03118.x)10.1111\/j.1365-2265.2007.03118.x"},{"key":"bib93","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1530\/ERC-16-0518","article-title":"Incidence of malignant tumours in patients with a non-functioning pituitary adenoma","volume":"24","author":"Olsson","year":"2017","unstructured":"Olsson DSHammarstrand CBryngelsson ILNilsson AGAndersson EJohannsson GRagnarsson O2017Incidence of malignant tumours in patients with a non-functioning pituitary adenoma. Endocrine-Related Cancer24227\u2013235. (https:\/\/doi.org\/10.1530\/ERC-16-0518)10.1530\/ERC-16-0518"},{"key":"bib94","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2730","article-title":"Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group","volume":"83","author":"Orme","year":"1998","unstructured":"Orme SMMcNally RJCartwright RABelchetz PE1998Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism832730\u20132734. (https:\/\/doi.org\/10.1210\/jcem.83.8.5007)"},{"key":"bib95","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11102-017-0841-7","article-title":"Guidelines versus real life practice: the case of colonoscopy in acromegaly","volume":"21","author":"Parolin","year":"2018","unstructured":"Parolin MDassie FRusso LMazzocut SFerrata MDe Carlo EMioni RFallo FVettor RMartini C2018Guidelines versus real life practice: the case of colonoscopy in acromegaly. Pituitary2116\u201324. (https:\/\/doi.org\/10.1007\/s11102-017-0841-7)10.1007\/s11102-017-0841-7"},{"key":"bib96","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000494725","article-title":"Hyperprolactinemia\/prolactinomas in the postmenopausal period: challenges in diagnosis and management","volume":"109","author":"Pekic","year":"2019a","unstructured":"Pekic SMedic Stojanoska MPopovic V2019aHyperprolactinemia\/prolactinomas in the postmenopausal period: challenges in diagnosis and management. Neuroendocrinology10928\u201333. (https:\/\/doi.org\/10.1159\/000494725)10.1159\/000494725"},{"key":"bib97","series-title":"Hormones and Cancer","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12672-018-0348-3","article-title":"Familial cancer clustering in patients with prolactinoma","volume":"10","author":"Pekic","year":"2019b","unstructured":"Pekic SSoldatovic IMiljic DStojanovic MDoknic MPetakov MPopovic V2019bFamilial cancer clustering in patients with prolactinoma. Hormones and Cancer1045\u201350. (https:\/\/doi.org\/10.1007\/s12672-018-0348-3)10.1007\/s12672-018-0348-3"},{"key":"bib98","series-title":"Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/JOE-18-0446","article-title":"Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects","volume":"240","author":"Pepe","year":"2019","unstructured":"Pepe SKorbonits MIacovazzo D2019Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects. Journal of Endocrinology240R21\u2013R45. (https:\/\/doi.org\/10.1530\/JOE-18-0446)10.1530\/JOE-18-0446"},{"key":"bib99","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1530\/EJE-08-0593","article-title":"Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident","volume":"159","author":"Pesatori","year":"2008","unstructured":"Pesatori ACBaccarelli AConsonni DLania ABeck-Peccoz PBertazzi PASpada A2008Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident. European Journal of Endocrinology159699\u2013703. (https:\/\/doi.org\/10.1530\/EJE-08-0593)10.1530\/EJE-08-0593"},{"key":"bib100","series-title":"Nature Reviews: Cancer","first-page":"505","article-title":"Insulin-like growth factors and neoplasia","volume":"4","author":"Pollak","year":"2004","unstructured":"Pollak MNSchernhammer ESHankinson SE2004Insulin-like growth factors and neoplasia. Nature Reviews: Cancer4505\u2013518. (https:\/\/doi.org\/10.1038\/nrc1387)"},{"key":"bib101","series-title":"Clinical Endocrinology","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2265.1998.00536.x","article-title":"Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group","volume":"49","author":"Popovic","year":"1998","unstructured":"Popovic VDamjanovic SMicic DNesovic MDjurovic MPetakov MObradovic SZoric SSimic MPenezic Z1998Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clinical Endocrinology49441\u2013445. (https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00536.x)10.1046\/j.1365-2265.1998.00536.x"},{"key":"bib102","series-title":"PLoS ONE","article-title":"Divergent effects of dioxin- or non-dioxin-like polychlorinated biphenyls on the apoptosis of primary cell culture from the mouse pituitary gland","volume":"11","author":"Raggi","year":"2016","unstructured":"Raggi FRusso DUrbani CSardella CManetti LCappellani DLupi ITomisti LMartino EMarcocci C2016Divergent effects of dioxin- or non-dioxin-like polychlorinated biphenyls on the apoptosis of primary cell culture from the mouse pituitary gland. PLoS ONE11 e0146729. (https:\/\/doi.org\/10.1371\/journal.pone.0146729)"},{"key":"bib103","series-title":"Nature Genetics","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease","volume":"47","author":"Reincke","year":"2015","unstructured":"Reincke MSbiera SHayakawa ATheodoropoulou MOsswald ABeuschlein FMeitinger TMizuno-Yamasaki EKawaguchi KSaeki Y2015Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nature Genetics4731\u201338. (https:\/\/doi.org\/10.1038\/ng.3166)10.1038\/ng.3166"},{"key":"bib104","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","article-title":"Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis","volume":"363","author":"Renehan","year":"2004","unstructured":"Renehan AGZwahlen MMinder CO\u2019Dwyer STShalet SMEgger M2004Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet3631346\u20131353. (https:\/\/doi.org\/10.1016\/S0140-6736(0416044-3)10.1016\/S0140-6736(04)16044-3"},{"key":"bib105","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","unstructured":"Ritvonen EL\u00f6yttyniemi EJaatinen PEbeling TMoilanen LNuutila PKauppinen-M\u00e4kelin RSchalin-J\u00e4ntti C2016Mortality in acromegaly: a 20-year follow-up study. Endocrine-Related Cancer23469\u2013480. (https:\/\/doi.org\/10.1530\/ERC-16-0106)10.1530\/ERC-16-0106"},{"key":"bib106","series-title":"Critical Reviews in Oncology\/Hematology","doi-asserted-by":"publisher","first-page":"103330","DOI":"10.1016\/j.critrevonc.2021.103330","article-title":"Exposure to endocrine disruptors and risk of breast cancer: a systematic review","volume":"161","author":"Rocha","year":"2021","unstructured":"Rocha PRSOliveira VDVasques CIDos Reis PEDAmato AA2021Exposure to endocrine disruptors and risk of breast cancer: a systematic review. Critical Reviews in Oncology\/Hematology161103330. (https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103330)10.1016\/j.critrevonc.2021.103330"},{"key":"bib107","series-title":"Endocrine Reviews","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights","volume":"28","author":"Samani","year":"2007","unstructured":"Samani AAYakar SLeRoith DBrodt P2007The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocrine Reviews2820\u201347. (https:\/\/doi.org\/10.1210\/er.2006-0001)10.1210\/er.2006-0001"},{"key":"bib108","series-title":"Breast Cancer","doi-asserted-by":"publisher","first-page":"302","DOI":"10.2325\/jbcs.14.302","article-title":"A rare case of invasive ductal carcinoma with hyperprolactinemia","volume":"14","author":"Sato","year":"2007","unstructured":"Sato TMuto IHasegawa MAono TOkada TTamura TSakai T2007A rare case of invasive ductal carcinoma with hyperprolactinemia. Breast Cancer14302\u2013306. (https:\/\/doi.org\/10.2325\/jbcs.14.302)10.2325\/jbcs.14.302"},{"key":"bib109","series-title":"Radiotherapy and Oncology","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.radonc.2012.04.024","article-title":"The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone","volume":"104","author":"Sattler","year":"2012","unstructured":"Sattler MGvan Beek APWolffenbuttel BHvan den Berg GSluiter WJLangendijk JAvan den Bergh AC2012The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiotherapy and Oncology 104125\u2013130. (https:\/\/doi.org\/10.1016\/j.radonc.2012.04.024)10.1016\/j.radonc.2012.04.024"},{"key":"bib110","series-title":"Neuro-Oncology","first-page":"1","article-title":"Driver mutations in USP8 wild-type Cushing\u2019s disease","volume":"21","author":"Sbiera","year":"2019","unstructured":"Sbiera SPerez-Rivas LGTaranets LWeigand IFlitsch JGraf EMonoranu C-MSaeger WHagel CHonegger J2019Driver mutations in USP8 wild-type Cushing\u2019s disease. Neuro-Oncology211273\u20131283."},{"key":"bib111","series-title":"Growth Hormone and IGF Research","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ghir.2012.09.003","article-title":"The role of the insulin-like growth factor-I receptor in malignancy: an update","volume":"22","author":"Seccareccia","year":"2012","unstructured":"Seccareccia EBrodt P2012The role of the insulin-like growth factor-I receptor in malignancy: an update. Growth Hormone and IGF Research22193\u2013199. (https:\/\/doi.org\/10.1016\/j.ghir.2012.09.003)10.1016\/j.ghir.2012.09.003"},{"key":"bib112","series-title":"Journal of the National Comprehensive Cancer Network","doi-asserted-by":"publisher","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","article-title":"Neuroendocrine and adrenal tumors, version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Shah","year":"2021","unstructured":"Shah MHGoldner WSBenson ABBergsland EBlaszkowsky LSBrock PChan JDas SDickson PVFanta P2021Neuroendocrine and adrenal tumors, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network19839\u2013868. (https:\/\/doi.org\/10.6004\/jnccn.2021.0032)10.6004\/jnccn.2021.0032"},{"key":"bib113","series-title":"New England Journal of Medicine","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","unstructured":"Shain AHYeh IKovalyshyn ISriharan ATalevich EGagnon ADummer RNorth JPincus LRuben B2015The genetic evolution of melanoma from precursor lesions. New England Journal of Medicine3731926\u20131936. (https:\/\/doi.org\/10.1056\/NEJMoa1502583)10.1056\/NEJMoa1502583"},{"key":"bib114","series-title":"Journal of Clinical Endocrinology and Metabolism","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","unstructured":"Sherlock MReulen RCAlonso AAAyuk JClayton RNSheppard MCHawkins MMBates ASStewart PM2009ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism944216\u20134223. (https:\/\/doi.org\/10.1210\/jc.2009-1097)10.1210\/jc.2009-1097"},{"key":"bib115","series-title":"Growth Hormone and IGF Research","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report","volume":"17","author":"Shevah","year":"2007","unstructured":"Shevah OLaron Z2007Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Hormone and IGF Research1754\u201357. (https:\/\/doi.org\/10.1016\/j.ghir.2006.10.007)10.1016\/j.ghir.2006.10.007"},{"key":"bib116","series-title":"Endocrine Connections","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1530\/EC-17-0171","article-title":"Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study","volume":"6","author":"Soto-Pedre","year":"2017","unstructured":"Soto-Pedre ENewey PJBevan JSLeese GP2017Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study. Endocrine Connections6580\u2013588. (https:\/\/doi.org\/10.1530\/EC-17-0171)10.1530\/EC-17-0171"},{"key":"bib117","series-title":"Frontiers in Endocrinology","doi-asserted-by":"publisher","first-page":"597573","DOI":"10.3389\/fendo.2020.597573","article-title":"Growth hormone receptor regulation in cancer and chronic diseases","volume":"11","author":"Strous","year":"2020","unstructured":"Strous GJAlmeida ADSPutters JSchantl JSedek MSlotman JANespital THassink GCMol JA2020Growth hormone receptor regulation in cancer and chronic diseases. Frontiers in Endocrinology11597573. (https:\/\/doi.org\/10.3389\/fendo.2020.597573)10.3389\/fendo.2020.597573"},{"key":"bib118","series-title":"European Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-20-1313","article-title":"A mutation of the \u03b2-domain in POU1F1 causes pituitary deficiency due to dominant PIT-1\u03b2 expression","volume":"185","author":"Suzuki","year":"2021","unstructured":"Suzuki SMatsuo KIto YKobayashi AKokumai TFuruya AUeda OMukao TYano KFujieda K2021A mutation of the \u03b2-domain in POU1F1 causes pituitary deficiency due to dominant PIT-1\u03b2 expression. European Journal of Endocrinology1851\u201312. (https:\/\/doi.org\/10.1530\/EJE-20-1313)10.1530\/EJE-20-1313"},{"key":"bib119","series-title":"Pituitary","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11102-016-0777-3","article-title":"Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells","volume":"20","author":"Tapella","year":"2017","unstructured":"Tapella LSesta ACassarino MFZunino VCatalano MGPecori Giraldi F2017Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells. Pituitary20311\u2013318. (https:\/\/doi.org\/10.1007\/s11102-016-0777-3)10.1007\/s11102-016-0777-3"},{"key":"bib120","series-title":"Endocrine-Related Cancer","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-16-0553","article-title":"Acromegaly is associated with increased cancer risk: a survey in Italy","volume":"24","author":"Terzolo","year":"2017","unstructured":"Terzolo MReimondo GBerchialla PFerrante EMalchiodi EDe Marinis LPivonello RGrottoli SLosa MCannavo S2017Acromegaly is associated with increased cancer risk: a survey in Italy. Endocrine-Related Cancer24495\u2013504. (https:\/\/doi.org\/10.1530\/ERC-16-0553)10.1530\/ERC-16-0553"},{"key":"bib121","series-title":"European Journal of Endocrinolology","doi-asserted-by":"publisher","first-page":"D1","DOI":"10.1530\/EJE-19-1009","article-title":"Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?","volume":"183","author":"Terzolo","year":"2020","unstructured":"Terzolo MPuglisi SReimondo GDimopoulou CStalla GK2020Thyroid and colorectal cancer screening in acromegaly patients: should it be different from that in the general population?European Journal of Endocrinolology183D1\u2013D13. (https:\/\/doi.org\/10.1530\/EJE-19-1009)10.1530\/EJE-19-1009"},{"key":"bib122","series-title":"Breast Cancer Research","article-title":"Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study","volume":"17","author":"Tikk","year":"2015","unstructured":"Tikk KSookthai DFortner RTJohnson TRinaldi SRomieu ITj\u00f8nneland AOlsen AOvervad KClavel-Chapelon F2015Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Research17 49. (https:\/\/doi.org\/10.1186\/s13058-015-0563-6)"},{"key":"bib123","series-title":"Journal of Endocrinology","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/JOE-11-0054","article-title":"AIP and its interacting partners","volume":"210","author":"Trivellin","year":"2011","unstructured":"Trivellin GKorbonits M2011AIP and its interacting partners. Journal of Endocrinology210137\u2013155. (https:\/\/doi.org\/10.1530\/JOE-11-0054)10.1530\/JOE-11-0054"},{"key":"bib124","series-title":"Neuroendocrinology","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000499382","article-title":"Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours","volume":"109","author":"Trouillas","year":"2019","unstructured":"Trouillas JDelgrange EWierinckx AVasiljevic AJouanneau EBurman PRaverot G2019Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours. Neuroendocrinology10970\u201376. (https:\/\/doi.org\/10.1159\/000499382)10.1159\/000499382"},{"key":"bib125","series-title":"Cancer Research","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","article-title":"Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women","volume":"66","author":"Tworoger","year":"2006","unstructured":"Tworoger SSSluss PHankinson SE2006Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Research662476\u20132482. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-3369)10.1158\/0008-5472.CAN-05-3369"},{"key":"bib126","series-title":"Cancer Research","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1158\/0008-5472.CAN-13-0665","article-title":"A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development","volume":"73","author":"Tworoger","year":"2013","unstructured":"Tworoger SSEliassen AHZhang XQian JSluss PMRosner BAHankinson SE2013A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development. Cancer Research734810\u20134819. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0665)10.1158\/0008-5472.CAN-13-0665"},{"key":"bib127","series-title":"Science","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","unstructured":"Vierimaa OGeorgitsi MLehtonen RVahteristo PKokko ARaitila ATuppurainen KEbeling TMSalmela PIPaschke R2006Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science3121228\u20131230. (https:\/\/doi.org\/10.1126\/science.1126100)10.1126\/science.1126100"},{"key":"bib128","series-title":"Endocrine","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12020-016-0868-y","article-title":"Cancerous leptomeningitis and familial congenital hypopituitarism","volume":"52","author":"Vujovic","year":"2016","unstructured":"Vujovic SVujosevic SKavaric SSopta JIvovic MSaveanu ABrue TKorbonits MPopovic V2016Cancerous leptomeningitis and familial congenital hypopituitarism. Endocrine52231\u2013235. (https:\/\/doi.org\/10.1007\/s12020-016-0868-y)10.1007\/s12020-016-0868-y"},{"key":"bib129","series-title":"Toxicological Sciences","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/toxsci\/52.2.154","article-title":"Carcinogenic effects of cadmium in the Noble (NBL\/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate","volume":"52","author":"Waalkes","year":"1999","unstructured":"Waalkes MPAnver MDiwan BA1999Carcinogenic effects of cadmium in the Noble (NBL\/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate. Toxicological Sciences52154\u2013161. (https:\/\/doi.org\/10.1093\/toxsci\/52.2.154)10.1093\/toxsci\/52.2.154"},{"key":"bib130","series-title":"Scientific Reports","doi-asserted-by":"publisher","first-page":"25998","DOI":"10.1038\/srep25998","article-title":"Plasma prolactin and breast cancer risk: a meta-analysis","volume":"6","author":"Wang","year":"2016","unstructured":"Wang MWu XChai FZhang YJiang J2016Plasma prolactin and breast cancer risk: a meta-analysis. Scientific Reports625998. (https:\/\/doi.org\/10.1038\/srep25998)10.1038\/srep25998"},{"key":"bib131","series-title":"International Journal of Cancer","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/ijc.33416","article-title":"Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank","volume":"148","author":"Watts","year":"2021","unstructured":"Watts ELFensom GKSmith Byrne KPerez-Cornago AAllen NEKnuppel AGunter MJHolmes MVMartin RMMurphy N2021Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. International Journal of Cancer1482274\u20132288. (https:\/\/doi.org\/10.1002\/ijc.33416)10.1002\/ijc.33416"},{"key":"bib132","series-title":"Frontiers in Endocrinology","article-title":"Sex-related differences in lactotroph tumor aggressiveness are associated with a specific gene-expression signature and genome instability","volume":"9","author":"Wierinckx","year":"2018","unstructured":"Wierinckx ADelgrange EBertolino PFran\u00e7ois PChanson PJouanneau ELachuer JTrouillas JRaverot G2018Sex-related differences in lactotroph tumor aggressiveness are associated with a specific gene-expression signature and genome instability. Frontiers in Endocrinology9 706. (https:\/\/doi.org\/10.3389\/fendo.2018.00706)"},{"key":"bib133","series-title":"Lancet","article-title":"In memory of William of Occam","volume":"354","author":"Wildner","year":"1999","unstructured":"Wildner M1999In memory of William of Occam. Lancet354 2172. (https:\/\/doi.org\/10.1016\/S0140-6736(0577085-9)"},{"key":"bib134","series-title":"Cancer Biology and Therapy","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1080\/15384047.2017.1294284","article-title":"Breast carcinoma associated with prolactinoma: a case report","volume":"18","author":"Zheng","year":"2017","unstructured":"Zheng YMo WYu YZou DHe XXia XHu J2017Breast carcinoma associated with prolactinoma: a case report. Cancer Biology and Therapy18132\u2013136. (https:\/\/doi.org\/10.1080\/15384047.2017.1294284)10.1080\/15384047.2017.1294284"}],"container-title":["Endocrine Oncology"],"original-title":[],"link":[{"URL":"https:\/\/eo.bioscientifica.com\/view\/journals\/eo\/2\/1\/EO-21-0033.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/2\/1\/EO-21-0033.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/2\/1\/EO-21-0033.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:50:24Z","timestamp":1784555424000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/eo\/article\/2\/1\/R1-R13\/1519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":134,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/eo-21-0033","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}